Trienbio Launches CELLAELE™ Ginseng Exo Focusing on Cell Regeneration

The innovative CELLAELE™ Ginseng Exo from Trienbio, led by CEO Kim Yong-soo, highlights a significant advancement in cell regeneration and anti-inflammatory efficacy. The product utilizes exosomes, which are extracellular vesicles with a diameter of approximately 50 nm to 200 nm, once mischaracterized as cellular waste during their discovery in the 1980s. Advances in biotechnology have revealed the complex and essential role of exosomes in intercellular communication.

Functioning as intracellular messengers, exosomes have a lipid bilayer structure that protects their water-soluble active components from harmful enzymes and oxidative reactions. This enables them to penetrate the stratum corneum and deliver signals effectively to target cells in the dermis, demonstrating optimal physical conditions for functional delivery.

CELLAELE™ Ginseng Exo is derived exclusively from the highly regarded Korean ginseng (Panax ginseng C.A.Meyer), differentiating it from American, Japanese, and Chinese varieties based on the ginsenoside structure and types vital for physiological activity. Nanoparticle tracking analysis revealed that CELLAELE™ Ginseng Exo has an average particle size of 112 nm and a concentration of 2.26 x 1011 particles/mL, showcasing a homogenous and high-concentration particle distribution. Transmission electron microscopy and cryo-electron microscopy have confirmed the maintenance of a clear spherical lipid bilayer structure within the 100-200 nm range.

Importantly, a detailed chromatographic quantitative analysis has indicated the simultaneous detection of seven ginsenosides (Rg1, Re, Rf, Rb1, Rc, Rb2, Rd) from within the exosomes. Among these, ginsenoside Rf, a rare component specific to Korean ginseng, has been clearly identified as an authenticity marker, validating the source material and demonstrating Trienbio's distinctive technological expertise.

The latest updates to the efficacy validation data confirm that CELLAELE™ Ginseng Exo transcends being a mere conceptual ingredient, establishing its role as a potent bioactive modulator in regenerative aesthetics.

In controlled studies, the product demonstrated significant effects on cell regeneration and anti-aging by reversing damage from inflammatory cytokine stimulation in fibroblast models. The expression of the collagen gene COL1A was restored to levels similar to pre-stimulation benchmarks, while COL3A, an essential marker of skin regeneration known as 'baby collagen,' significantly increased beyond baseline levels.

Moreover, within environments susceptible to UVB-induced aging, it exhibited notable proficiency in defending against oxidative stress. Observations showed a marked reduction in the expression of the collagen-degrading enzyme MMP-1 following treatment with the ginseng exosome, indicating strong photoprotective effects.

CELLAELE™ Ginseng Exo also evidenced a capability to inhibit the generation of chronic inflammatory compounds. In trials involving LPS-induced inflammation, the exosome significantly reduced nitric oxide levels in a concentration-dependent manner. This demonstrates its powerful ability to communicate across species boundaries, effectively suppressing the expression of inflammation-related genes, thus contributing to its anti-inflammatory synergy.